Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04722341 · ClinicalTrials.gov registry record · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
A NA study of Breast Cancer and Colorectal Cancer, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 175
- Enrollment target
- 2
- Study locations
NCT04722341: Recruiting NA study of Breast Cancer and Colorectal Cancer, sponsored by Cedars-Sinai Medical Center.
NCT04722341 is a NA study of Breast Cancer and Colorectal Cancer that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 175 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04722341, a NA study of Breast Cancer and Colorectal Cancer, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test whether the timing of meals can improve treatment adverse events, influence tumor biology and alter a person's mood and behaviors.
Primary Outcome
Measures whether participants achieve either a pathologic complete response (no invasive cancer is found in the removed tumor or sampled lymph nodes) or organ preservation at the end of treatment. For rectal cancer, organ preservation is defined as a complete or near-complete clinical response after therapy that allows the patient to safely avoid surgery, based on findings from exam, endoscopy, and MRI. Quantified as a percentage (%).
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Time-Restricted Eating (TRE)
Study Locations (2)
Alabama
- The University of Alabama at Birmingham - Birmingham
California
- Cedars-Sinai Medical Center - West Hollywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT04722341 shows while recruiting
NCT04722341 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT04722341 reports a single indexed study location in Alabama, California.
Frequently Asked Questions
What is clinical trial NCT04722341 about?
NCT04722341 is a clinical study titled "Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators". The purpose of this study is to test whether the timing of meals can improve treatment adverse events, influence tumor biology and alter a person's mood and behaviors.
What is the current status of trial NCT04722341?
This trial is currently recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2022-01-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04722341 study?
This clinical trial studies the following conditions: Breast Cancer, Colorectal Cancer.
What interventions are being tested in trial NCT04722341?
The interventions under investigation include: Control (BEHAVIORAL), Time-Restricted Eating (TRE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04722341?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04722341 being conducted?
This trial has 2 study locations across Alabama, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04722341's enrollment target sits among peer trials
175 416th of 1224 higher than 808 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
- NCT05335876 · 175 participants · Phase 3
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI